Roger B. Cohen, MD
Articles
Dr. Cohen on Potential With CAR T-Cell Therapy in Medullary Thyroid Cancer
April 19th 2022Roger B. Cohen, MD, is a professor of medicine at the Hospital of the University of Pennsylvania (Penn) and associate director of clinical research at Penn's Abramson Cancer Center. Along with his colleagues at Penn, he is investigating a novel CAR T-cell product as a treatment for adults with medullary thyroid cancer (MTC).
Read More
GFRα4 May Represent a Unique Therapeutic Target in Medullary Thyroid Cancer
April 19th 2022Roger B. Cohen, MD, is a professor of medicine at the Hospital of the University of Pennsylvania (Penn) and associate director of clinical research at Penn's Abramson Cancer Center. Along with his colleagues at Penn, he is investigating a novel CAR T-cell product as a treatment for adults with medullary thyroid cancer (MTC).
Read More
Dr. Cohen on Diversifying the Patient Population for a Clinical Trial in Medullary Thyroid Cancer
April 19th 2022Roger B. Cohen, MD, is a professor of medicine at the Hospital of the University of Pennsylvania (Penn) and associate director of clinical research at Penn's Abramson Cancer Center. Along with his colleagues at Penn, he is investigating a novel CAR T-cell product as a treatment for adults with medullary thyroid cancer (MTC).
Read More
